These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Risk factors for peptic ulcer disease in renal transplant patients--11 years of experience from a single center. Chen KJ; Chen CH; Cheng CH; Wu MJ; Shu KH Clin Nephrol; 2004 Jul; 62(1):14-20. PubMed ID: 15267008 [TBL] [Abstract][Full Text] [Related]
23. [Gastroduodenal ulcer--changes in surgical therapy by long-term drug treatment]. Peitsch W Zentralbl Chir; 1986; 111(23):1433-40. PubMed ID: 2881413 [TBL] [Abstract][Full Text] [Related]
25. [Current status of medical and surgical therapy of ulcer]. Tesauro B Minerva Chir; 1987 Oct; 42(19):1443-5. PubMed ID: 3683900 [No Abstract] [Full Text] [Related]
26. [Peptic ulcer in the elderly--endoscopy in suspected ulcer. Therapy always includes proton pump inhibitor]. Pfaffenbach B; Orth KH; Langer M; Stabenow-Lohbauer U; Lux G MMW Fortschr Med; 2000 Jun; 142(24):28-32. PubMed ID: 10895578 [TBL] [Abstract][Full Text] [Related]
27. [Peptic ulcer: current therapy]. Pieragnoli E G Clin Med; 1987 Apr; 68(4):197-209. PubMed ID: 2886387 [No Abstract] [Full Text] [Related]
28. [Controversy and trends in ulcer therapy. 1: Treatment of ulcer manifestation]. Berndt H Z Arztl Fortbild (Jena); 1993 Aug; 87(8):635-42. PubMed ID: 8379202 [No Abstract] [Full Text] [Related]
29. Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs. Ray WA; Chung CP; Stein CM; Smalley WE; Hall K; Arbogast PG; Griffin MR Gastroenterology; 2007 Sep; 133(3):790-8. PubMed ID: 17854591 [TBL] [Abstract][Full Text] [Related]
30. [Role of prostanoids in the pathogenesis and therapy of peptic ulcer]. Fich A; Stalnikowicz R; Goldin E; Eliakim R; Wengrower D; Ligumsky M; Karmeli F; Rachmilewitz D Harefuah; 1986 Nov; 111(10):292-5. PubMed ID: 3817615 [No Abstract] [Full Text] [Related]
31. Recurrence of peptic ulcer in uraemic and non-uraemic patients after Helicobacter pylori eradication: a 2-year study. Tseng GY; Lin HJ; Fang CT; Yang HB; Tseng GC; Wang PC; Hung TL; Deng YC; Cheng YT; Huang CH Aliment Pharmacol Ther; 2007 Sep; 26(6):925-33. PubMed ID: 17767477 [TBL] [Abstract][Full Text] [Related]
32. Your CE topic this month (No. 9). Peptic ulcer disease. Perentesis GP; Kirschenbaum HL; Piltz GW J Pract Nurs; 1983; 33(8):35-43. PubMed ID: 6140312 [No Abstract] [Full Text] [Related]
33. [Current viewpoints on conservative ulcer therapy]. Börsch G Med Welt; 1983 Mar; 34(10):316-20. PubMed ID: 6843329 [No Abstract] [Full Text] [Related]
34. Stress-related mucosal disease. Pathophysiology, prevention, and treatment. Fisher RL; Pipkin GA; Wood JR Crit Care Clin; 1995 Apr; 11(2):323-45. PubMed ID: 7788535 [TBL] [Abstract][Full Text] [Related]
35. Some aspects of the critical evaluation of peptic ulcer therapy in patients. Mózsik G; Bertelli A; Deak G; Nagy L; Patty I; Simon L; Tárnok F; Jávor T Int J Clin Pharmacol Res; 1985; 5(6):447-55. PubMed ID: 4093220 [TBL] [Abstract][Full Text] [Related]
36. Medical management of peptic ulcer. Mitra K J Assoc Physicians India; 1987 Mar; 35(3):247-9. PubMed ID: 3611013 [No Abstract] [Full Text] [Related]
38. [Current trends in the pharmacotherapy of peptic ulcer (a review of the literature)]. Degtiareva II Vrach Delo; 1985 Aug; (8):45-50. PubMed ID: 3907131 [No Abstract] [Full Text] [Related]
40. [Peptic ulcer and its treatment modalities in medicine]. De Miranda AC Acta Med Port; 1998 Jan; 11(1):77-9. PubMed ID: 9542182 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]